Endpoints News的动态

In today's Endpoints News health tech newsletter, I caught up with Peter Ax, the CEO of UpScriptHealth, the telehealth company behind Pfizer's new direct-to-consumer site (and much of the industry's DTC movement). UpScript's growth underscores the industry's appetite for using telehealth to sell to patients directly. The company, which has already notched more than 50 partnerships with individual drug brands or therapies, will have more than 30 new partnerships this year and expects to add more than 50 in 2025, Ax told me. Compare that to a few years back, in 2022, when UpScript launched only seven new partnerships. “We're in discussions probably with every major pharma company in the world at this point,” he said. “There's extraordinary attention to this. I think the general consensus is this is a new channel of distribution and a new way to treat patients, and it's being embraced in a really significant way.” Read more about our chat in the newsletter (linked below). Also in the latest dispatch, Ngai Yeung got the scoop on PatientPartner's seed funding round. The San Diego-based startup works with drug and medical device companies to connect volunteer mentors to prospective patients, the goal being to both attract patients and improve medication adherence. Subscribe here to get our newsletters straight to your inbox every Tuesday and Thursday: https://lnkd.in/eKkWMGuw https://lnkd.in/e8zxa5ep